izpis_h1_title_alt

Application of quality by design principles to the development of oral lyophilizates containing olanzapine
ID Bjelošević Žiberna, Maja (Avtor), ID Ahlin Grabnar, Pegi (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (1,83 MB)
MD5: B140DFBBA6F6F019E8400C24BF47A2F5
URLURL - Izvorni URL, za dostop obiščite https://www.mdpi.com/1999-4923/15/7/1967 Povezava se odpre v novem oknu

Izvleček
Oral lyophilizates are intended for application to the oral cavity or for dispersing in water. The purposes of this research were: (i) to set up the quality by design approach in the development of oral lyophilizates for drug incorporation; and (ii) to evaluate the established approach by comparing its outcomes with experimentally obtained results. Within the knowledge space, properties about drugs, excipients, and the lyophilization process were acquired, followed by the determination of critical quality attributes via risk identification. Risks were assessed by failure mode and effective analysis, which recognized critical material attributes, i.e., type, concentration, particle size, solubility of drug and excipients, while as main critical process parameters, cooling rate, shelf temperature, and chamber pressure during drying were pointed out. Additionally, design space was established using the Minitab$^®$ 17 software and valued with an 88.69% coefficient of determination. A detailed comparison between the model and experimental results revealed that the proposed optimal compositions match in the total concentration of excipients (6%, w/w) in the pre-lyophilized liquid formulation, among which mannitol predominates. On the other hand, a discrepancy regarding the presence of gelatin was detected. The conclusion was that the set model represents a suitable onset toward optimization of drug-based oral lyophilizates development, preventing unnecessary investment of time and resources.

Jezik:Angleški jezik
Ključne besede:oral lyophilizate, lyophilization, quality by design, disintegration time, Minitab$^®$
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:FFA - Fakulteta za farmacijo
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2023
Št. strani:16 str.
Številčenje:Vol. 15, iss. 7, art. 1967
PID:20.500.12556/RUL-148360 Povezava se odpre v novem oknu
UDK:542.47:661.12
ISSN pri članku:1999-4923
DOI:10.3390/pharmaceutics15071967 Povezava se odpre v novem oknu
COBISS.SI-ID:160781059 Povezava se odpre v novem oknu
Datum objave v RUL:18.08.2023
Število ogledov:610
Število prenosov:181
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Pharmaceutics
Skrajšan naslov:Pharmaceutics
Založnik:MDPI
ISSN:1999-4923
COBISS.SI-ID:517949977 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:peroralni liofilizati, liofilizacija, kakovost po zasnovi, čas razpadanja, Minitab$^®$, sušenje, farmacevtska tehnologija

Projekti

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P1-0189
Naslov:Farmacevtska tehnologija: od dostavnih sistemov učinkovin do terapijskih izidov zdravil pri otrocih in starostnikih

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:L1-3160
Naslov:Razvoj visokokoncentriranih proteinskih formulacij in vrednotenje kinetike absorpcije po subkutani aplikaciji

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj